Bariatric Education for Women With Obesity and Endometrial Cancer
NCT ID: NCT05396794
Last Updated: 2025-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
26 participants
OBSERVATIONAL
2023-08-30
2025-04-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Menstrual Irregularities and Endometrial Pathology in Women Undergoing Bariatric Surgery
NCT01473186
Long Term Effect of Bariatric Surgery on Pelvic Floor Disorders
NCT04575987
Effects of Bariatric Surgery on Breast Density Improvement and Impact on Breast Cancer Risk in Severe Obese Patients
NCT04170335
Energy Expenditure and Gastric Bypass Surgery
NCT00863993
Effects of Bariatric Surgery on Pelvic Floor Fonctions in Obese Women
NCT02331186
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
If the patient is in group 1, she will get standard education for weight loss, which will be provided by her Gynecologic Oncologist. This will take about 15 minutes.
Standard weight loss education
Participants will be randomized and given the standard weight loss education by the Gynecologic Oncology provider.
Video Group
If the patient is in group 2, she will get standard education for weight loss provided by her Gynecologic Oncologist. Then she will be asked to view a 15-minute video to get information regarding obesity, the relationship of obesity and endometrial cancer, and the safety and benefits of bariatric surgery. These will take about 30 minutes.
Standard weight loss education + Educational Video
Participants will be randomized and given the standard weight loss education by the Gynecologic Oncology provider followed by a 15-minute educational video detailing the benefits of weight loss.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard weight loss education
Participants will be randomized and given the standard weight loss education by the Gynecologic Oncology provider.
Standard weight loss education + Educational Video
Participants will be randomized and given the standard weight loss education by the Gynecologic Oncology provider followed by a 15-minute educational video detailing the benefits of weight loss.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have pathologically-confirmed endometrial cancer
* Have completed initial therapy (e.g. surgery, hormonal therapy, vaginal cuff brachytherapy, or a combination of these modalities) and require no further interventions related to cancer care. Patients taking hormonal therapy as part of cancer treatment may be included.
Exclusion Criteria
* Have previously undergone bariatric surgery
* Requires ongoing cancer treatment with chemotherapy or whole pelvic radiation.
* Poor surgical candidate secondary to comorbidities or performance status.
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oklahoma
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura L Holman, MD
Role: PRINCIPAL_INVESTIGATOR
University of Oklahoma Stephenson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OU-SCC-BAREDU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.